Insider Trading Alert - BPOP, MDVN And TEP Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

Yesterday, May 20, 2015, 100 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $186.58 to $190,703,600.00.

Highlighted Stocks Traded by Insiders:

Popular (BPOP) - FREE Research Report

Monzon Gilberto, who is Executive Vice President at Popular, sold 3,000 shares at $34.20 on May 20, 2015. Following this transaction, the Executive Vice President owned 33,059 shares meaning that the stake was reduced by 8.32% with the 3,000-share transaction.

The shares most recently traded at $33.83, down $0.37, or 1.09% since the insider transaction. Historical insider transactions for Popular go as follows:

  • 4-Week # shares sold: 13,828
  • 12-Week # shares sold: 13,828
  • 24-Week # shares sold: 13,828

The average volume for Popular has been 751,400 shares per day over the past 30 days. Popular has a market cap of $3.5 billion and is part of the financial sector and banking industry. Shares are down 0.65% year-to-date as of the close of trading on Wednesday.

Popular, Inc., through its subsidiaries, provides various retail and commercial banking products and services primarily to institutional and retail customers. The company accepts various deposit products. Currently, there is 1 analyst who rates Popular a buy, 1 analyst rates it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on BPOP - FREE

TheStreet Quant Ratings rates Popular as a hold. The company's strengths can be seen in multiple areas, such as its solid stock price performance, expanding profit margins and growth in earnings per share. However, as a counter to these strengths, we also find weaknesses including disappointing return on equity, weak operating cash flow and deteriorating net income. Get the full Popular Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Medivation (MDVN) - FREE Research Report

Bierly Rick, who is Chief Financial Officer at Medivation, sold 1,000 shares at $130.00 on May 20, 2015. Following this transaction, the Chief Financial Officer owned 14,841 shares meaning that the stake was reduced by 6.31% with the 1,000-share transaction.

The shares most recently traded at $130.43, up $0.43, or 0.33% since the insider transaction. Historical insider transactions for Medivation go as follows:

  • 4-Week # shares sold: 4,170
  • 12-Week # shares sold: 129,999
  • 24-Week # shares sold: 233,799

The average volume for Medivation has been 993,200 shares per day over the past 30 days. Medivation has a market cap of $9.9 billion and is part of the health care sector and drugs industry. Shares are up 30.79% year-to-date as of the close of trading on Wednesday.

Medivation, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies to treat serious diseases in the United States. It offers XTANDI for the treatment of post-chemotherapy metastatic castration-resistant prostate cancer (mCRPC) patients. The company has a P/E ratio of 33.8. Currently, there are 11 analysts who rate Medivation a buy, 1 analyst rates it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on MDVN - FREE

TheStreet Quant Ratings rates Medivation as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, solid stock price performance and notable return on equity. However, as a counter to these strengths, we find that the company's profit margins have been poor overall. Get the full Medivation Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Tallgrass Energy Partners (TEP) - FREE Research Report

Towner Terrance Daniel, who is Director at Tallgrass Energy Partners, bought 1,000 shares at $50.43 on May 20, 2015. Following this transaction, the Director owned 8,000 shares meaning that the stake was boosted by 14.29% with the 1,000-share transaction.

The shares most recently traded at $50.36, down $0.07, or 0.14% since the insider transaction. Historical insider transactions for Tallgrass Energy Partners go as follows:

  • 4-Week # shares bought: 46
  • 12-Week # shares bought: 46
  • 24-Week # shares bought: 13,771

The average volume for Tallgrass Energy Partners has been 328,900 shares per day over the past 30 days. Tallgrass Energy Partners has a market cap of $3.0 billion and is part of the basic materials sector and energy industry. Shares are up 13.11% year-to-date as of the close of trading on Wednesday.

Tallgrass Energy Partners, LP acquires, owns, develops, and operates various midstream energy assets in North America. The company operates through three segments: Natural Gas Transportation & Logistics; Crude Oil Transportation & Logistics; and Processing & Logistics. The stock currently has a dividend yield of 4.12%. The company has a P/E ratio of 33.2. Currently, there are 3 analysts who rate Tallgrass Energy Partners a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on TEP - FREE

TheStreet Quant Ratings rates Tallgrass Energy Partners as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, impressive record of earnings per share growth, compelling growth in net income, expanding profit margins and good cash flow from operations. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. Get the full Tallgrass Energy Partners Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

More from Markets

AMD Rises Above the Competition; Loan Losses Mount for Big Banks -- ICYMI

AMD Rises Above the Competition; Loan Losses Mount for Big Banks -- ICYMI

McKesson Internal Review Clears Senior Management of Wrongdoing on Opioids

McKesson Internal Review Clears Senior Management of Wrongdoing on Opioids

Starbucks Surprises Wall Street With U.S. Sales Up a Paltry 2%

Starbucks Surprises Wall Street With U.S. Sales Up a Paltry 2%

Dow Jumps 238 Points as S&P 500, Nasdaq Also Climb

Dow Jumps 238 Points as S&P 500, Nasdaq Also Climb

Why Nashville, Denver, LA Should Reconsider Bids for Amazon HQ2

Why Nashville, Denver, LA Should Reconsider Bids for Amazon HQ2